Amazon Extends Position as the World’s Largest Corporate Buyer of Renewable Energy
20.4.2022 13:00:00 EEST | Business Wire | Press release
Amazon (NASDAQ: AMZN) today announced 37 new renewable energy projects around the world, marking significant progress on its path to power 100% of its operations with renewable energy by 2025—five years ahead of the original target of 2030. The new projects increase the capacity of Amazon’s renewable energy portfolio by nearly 30%, from 12.2 gigawatts (GW) to 15.7 GW, and bring the total number of renewable energy projects to 310 across 19 countries. The additional 3.5 GW of clean energy capacity from these new projects extends Amazon’s leadership position as the world’s largest corporate buyer of renewable energy, and advances its efforts to meet The Climate Pledge, a commitment to be net-zero carbon by 2040—10 years ahead of the Paris Agreement.
“Our commitment to protecting the planet and limiting Amazon’s impact on the environment has led us to become the largest corporate buyer of renewable energy in the world in both 2020 and 2021. Given the growth of our business, and our mission to run 100% of Amazon’s operations on renewable energy, we aren’t slowing our renewable investments down,” said Andy Jassy, CEO of Amazon. “We now have 310 wind and solar projects across 19 countries, and are working hard to reach our goal of powering 100% of our business on renewable energy by 2025—five years ahead of our original target of 2030.”
The 37 new projects announced today are located across the U.S., Spain, France, Australia, Canada, India, Japan, and the United Arab Emirates. They vary in project type and size, with three new wind farms, 26 new solar farms, and eight new rooftop solar installations at its buildings around the world. As a result of these projects, Amazon now has a total of 310 renewable energy projects, including 134 wind and solar farms and 176 rooftop solar projects.
Once operational, Amazon’s 310 projects are expected to produce 42,000 gigawatt hours (GWh) of renewable energy each year—enough electricity output to power 3.9 million U.S. homes annually. The carbon-free energy generated by these projects will also help avoid 17.3 million metric tons of carbon emissions annually, avoiding the equivalent of the annual emissions of more than 3.7 million cars in the U.S. each year.
Amazon also continues to invest in renewable energy projects paired with energy storage. The energy storage systems allow Amazon to store clean energy produced by its solar projects and deploy it when solar energy is not available, such as in the evening hours, or during periods of high demand. This strengthens the climate impact of Amazon’s clean energy portfolio by enabling carbon-free electricity throughout more parts of the day. The new projects include a 300-megawatt (MW) solar project paired with 150 MW of battery storage in Arizona and a 150 MW solar project paired with 75 MW of battery storage in California. Combined, the two projects double Amazon’s total announced solar paired with energy storage from 220 MW to 445 MW.
Below are more details about the latest series of renewable energy projects announced today, which will supply clean energy for Amazon’s operations, including its corporate offices, fulfillment centers, and Amazon Web Services (AWS) data centers that support millions of customers globally:
- 23 projects in the U.S., spread across 13 states: This brings Amazon’s total clean energy procurement in the U.S. from 7.2 GW to 10.4 GW. Notably, the new projects include Amazon’s largest renewable energy project (by capacity) announced to date, which is a 500 MW solar farm in Texas. The announcement also includes the company’s first renewable energy projects in Missouri. The remaining projects are in Arizona, Arkansas, California, Delaware, Georgia, Illinois, Indiana, Mississippi, Ohio, Oklahoma, and Virginia.
- Five new projects in Spain: The company added an additional 314 MW of renewable energy capacity in Spain, bringing its total investment to 1.4 GW in the country. The five new projects include three solar farms and two wind farms, bringing Amazon’s total renewable energy projects in Spain to 14.
- A second renewable energy project in France: Amazon announced its second solar project in France, which brings the company’s total renewable energy capacity announced to date to 38 MW in the country.
- Eight additional rooftop solar projects: The company added its first rooftop solar project in the United Arab Emirates, which is a 2.7 MW installation in Dubai. Amazon also announced seven rooftop solar projects in Australia, Canada, India, and Japan totaling over 5 MW of clean energy capacity.
To see Amazon’s renewable energy projects around the world, visit the company’s renewable energy project interactive map.
“As number one on CEBA’s Deal Tracker Top 10 for the second year in a row, Amazon continues to demonstrate its commitment to advancing clean energy. Amazon’s recent announcement highlights the increasingly sophisticated strategies used by energy customers to deploy carbon-free energy projects across the nation and the world, and the critical role energy customers play in optimizing emissions reductions,” said Miranda Ballentine, CEO of Clean Energy Buyers Association (CEBA).
“Amazon continues to be a leader in rapidly scaling up renewable energy projects here in the U.S. This increasingly includes hybrid projects that pair energy storage with renewable energy generation, unlocking the ability to use clean reliable energy throughout all hours of the day,” said Heather Zichal CEO of the American Clean Power Association (ACP).
Amazon co-founded The Climate Pledge in 2019, committing to reach net-zero carbon by 2040—10 years ahead of the Paris Agreement. The Pledge now has more than 300 signatories, including Best Buy, IBM, Microsoft, PepsiCo, Siemens, Unilever, Verizon, and Visa. To reach its goal, Amazon will continue to reduce emissions across its operations by taking real business actions and establishing a path to power its operations with 100% renewable energy, five years ahead of the company’s original target of 2030. Amazon is also delivering on its Shipment Zero vision to make all Amazon shipments net-zero carbon, with 50% net-zero carbon by 2030, and purchasing 100,000 electric delivery vehicles, the largest order ever of electric delivery vehicles. The company is also investing $2 billion in the development of decarbonizing services and solutions through the Climate Pledge Fund. For more information, visit https://sustainability.aboutamazon.com/.
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are some of the products and services pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.
About Amazon Web Services
For over 15 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud offering. AWS has been continually expanding its services to support virtually any cloud workload, and it now has more than 200 fully featured services for compute, storage, databases, networking, analytics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 84 Availability Zones within 26 geographic regions, with announced plans for 24 more Availability Zones and eight more AWS Regions in Australia, Canada, India, Israel, New Zealand, Spain, Switzerland, and the United Arab Emirates. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220420005101/en/
Contact information
Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
